Amanote Research
Register
Sign In
P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1728
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
S. Zhao
Y. Jia
T. Jiang
X. Li
W. Li
G. Gao
C. Zhao
Y. He
X. Chen
C. Su
S. Ren
C. Zhou
Publisher
Elsevier BV
Related search
P104 Anti-Pd-1 Combination Therapy in Second or Later Lines in Patients With Advanced Non Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P013 Anti-Pd-1 Combination Therapy as Second Line Treatment or Beyond in Patients With Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors
Scientific Reports
Multidisciplinary
P1.01-18 Immunosenescence Correlates With Progression Upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer
Medicinski podmladak
PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer
Oncotarget
Oncology
